Analyze Diet
Journal of equine veterinary science2021; 98; 103375; doi: 10.1016/j.jevs.2021.103375

Effects of Intravenous Flunixin Meglumine, Phenylbutazone, and Acupuncture on Ocular Pain Scores in the Horse: A Pilot Study.

Abstract: In this controlled, blinded, randomized block pilot study, the main objective was to evaluate the effectiveness of intravenous flunixin meglumine, phenylbutazone, and acupuncture on ocular pain relief using a multifactorial pain scale in the horse. Four experimental horses underwent corneal epithelial debridement in four sessions, when a randomly selected treatment or a control was used. All horses were pain scored before corneal wounding, then at 18 time points, when 11 parameters were allocated. Differences in the area under the curve of pain scores between the treatment groups were analyzed using a paired t-test. Corneal pain was significantly reduced by the third postoperative day (P = .03) when all 11 parameters were considered. Five ocular signs showed significant differences between treatments and proved to be good indicators of ocular pain. The other parameters (heart rate, corneal touch threshold, respond to palpation, and three behavioral parameters) were determined to be irrelevant when evaluating the degree of pain. When considering the five ocular signs, the lowest pain score was attributed to the flunixin meglumine group (1114), followed by the electroacupuncture group (1356), the phenylbutazone group (1397), and the control group (1580). There were significantly lower pain scores (P = .01) in the flunixin meglumine group when compared with those recorded in the control group during the first 46 hours. Flunixin meglumine was the most effective treatment at reducing ocular pain in the horse. In the future, a reduction in the number of pain score parameters and more precisely defined image evaluation criteria could be used.
Publication Date: 2021-01-06 PubMed ID: 33663725DOI: 10.1016/j.jevs.2021.103375Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial
  • Veterinary

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research studied the efficiency of intravenous flunixin meglumine, phenylbutazone, and acupuncture in providing ocular pain relief in horses, with flunixin meglumine proving to be the most effective.

Research Objectives and Methodology

  • The main goal of this study was to assess the efficacy of three separate treatment methods for ocular pain relief in horses. These methods included intravenous flunixin meglumine, phenylbutazone, and acupuncture.
  • A controlled, randomized block pilot study was carried out on four experimental horses that faced corneal epithelial debridement across four sessions.
  • In each session, a different treatment or a control, chosen randomly, was used on the horses.
  • A multifactorial pain scale was used to measure pain in each horse on a variety of parameters. This was done pre-injury, and then at 18 distinct time points post-injury.

Data Analysis and Findings

  • The research analyzed differences in the area under the curve of pain scores between the different treatment groups using a paired t-test. This analysis showed corneal pain reduction by the third postoperative day.
  • Out of 11 parameters, five ocular signs showed significant differences between the treatment types and were identified as good indicators of ocular pain. This leaves the remaining parameters to be heart rate, corneal touch threshold, response to palpation, and three behavioral parameters which were found to be irrelevant in assessing pain.
  • Looking at the effective five ocular signs, flunixin meglumine group recorded the lowest ocular pain score. This was followed by the electroacupuncture group, the phenylbutazone group, and lastly, the control group.
  • Comparatively, Flunixin meglumine group showcased significantly lower pain scores when compared to the control group during the first 46 hours.
  • The study concluded that the intravenous administration of Flunixin meglumine was the most effective treatment for relieving ocular pain in horses.

Further Research

  • The authors of the study proposed that future research could be directed towards reducing the number of pain score parameters and developing more intricately defined image evaluation criteria.

Cite This Article

APA
Makra Z, Csereklye N, Riera MM, McMullen RJ, Veres-Nyéki K. (2021). Effects of Intravenous Flunixin Meglumine, Phenylbutazone, and Acupuncture on Ocular Pain Scores in the Horse: A Pilot Study. J Equine Vet Sci, 98, 103375. https://doi.org/10.1016/j.jevs.2021.103375

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 98
Pages: 103375

Researcher Affiliations

Makra, Zita
  • Equine Department and Clinic, University of Veterinary Medicine Budapest, Hungary. Electronic address: makra.zita@univet.hu.
Csereklye, Nóra
  • Equine Department and Clinic, University of Veterinary Medicine Budapest, Hungary.
Riera, Marian Matas
  • Memvet Oftalmologia, Palma, Mallorca, Spain.
McMullen, Richard J
  • Auburn University, JT Vaughan Large Animal Teaching Hospital, Auburn, AL.
Veres-Nyéki, Kata
  • Royal Veterinary College, Anaesthesia and Analgesia Service, London, UK.

MeSH Terms

  • Acupuncture Therapy / veterinary
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Clonixin / analogs & derivatives
  • Horses
  • Pain / veterinary
  • Phenylbutazone / therapeutic use
  • Pilot Projects

Citations

This article has been cited 1 times.
  1. Fikri F, Hendrawan D, Wicaksono AP, Purnomo A, Khairani S, Chhetri S, Maslamama ST, Purnama MTE. Incidence, risk factors, and therapeutic management of equine colic in Lamongan, Indonesia. Vet World 2023;16(7):1408-1414.